Galapagos NV
GLPG
#5078
Rank
โ‚น177.62 B
Marketcap
โ‚น2,645
Share price
0.00%
Change (1 day)
8.58%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -โ‚น37.14

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น38.85. In 2025 the company made an earnings per share (EPS) of โ‚น545.66 an increase over its 2024 EPS that were of โ‚น111.16.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น37.14-106.81%
2025โ‚น545.66390.86%
2024โ‚น111.16-67.16%
2023โ‚น338.46-199.64%
2022-โ‚น339.6799.03%
2021-โ‚น170.67-68.98%
2020-โ‚น550.21-298.06%
2019โ‚น277.80-554.64%
2018-โ‚น61.10-77.18%
2017-โ‚น267.79-326.21%
2016โ‚น118.38-134.19%
2015-โ‚น346.24-371.34%
2014โ‚น127.60-445.98%
2013-โ‚น36.8832.88%
2012-โ‚น27.76-82.07%
2011-โ‚น154.83-817.9%
2010โ‚น21.5712.73%
2009โ‚น19.13-120.79%
2008-โ‚น92.01-37.67%
2007-โ‚น147.6239.64%
2006-โ‚น105.7228.17%
2005-โ‚น82.486.25%
2004-โ‚น77.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น833.27-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น344.19-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น196.14-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น244.14-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น339.30-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น662.89-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น370.68-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น58.18 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น130.67-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel